期刊
RHEUMATOLOGY
卷 47, 期 -, 页码 V31-V32出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/ken266
关键词
Provisional core set; Systemic sclerosis; Scleroderma; Response measure; Clinical trials; Combined Response Index
类别
资金
- NIAMS NIH HHS [U01 AR055057-01, K23 AR053858, K23 AR053858-01A1, U01 AR055057] Funding Source: Medline
SSc can be associated with a high morbidity and mortality. Due to the complexity and heterogeneity of the disease, a composite response measure that will capture differing organ involvements and patient-reported outcomes is desirable. Recently, with participation of the Scleroderma Clinical Trial Consortium, a standardized core set of items were proposed for SSc clinical trials using a structured Delphi exercise. The Delphi exercise identified 11 domains relevant to SSc clinical trials. Currently, efforts are under way to develop a combined response index for clinical trials in diffuse cutaneous SSc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据